Inogen, Inc. (INGN) is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid first-quarter 2024 performance and a strong product portfolio, looks promising. However, issues like stiff competition and forex volatility are major downsides.The Zacks Rank #3 (Hold) company’s shares have risen 21% year to date compared with 20.9% growth of the industry. The S&P 500 has increased 18.3% during the same time frame.The re ...